Who invested in Climb Bio

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 7 months ago

Funding summaryUpdated 26 Oct 2026

$110Mraised across 1 round since 2026, from 1 source

Latest round: Round, $110MApr 2026
Investors: 5

See who backed them

The rounds

Apr 2026
Round$110M
Source recordedSEC filing: $110M sold

Founders and team

From Climb Bio's own website: 2 on the team.

Ashley JonesSenior Vice President, People & Workforce Strategy
Bo CumboBoard Member

Everyone who backed them

RA Capital ManagementPrivate equity1round

Janus Henderson InvestorsPrivate equity1round

Cormorant Asset ManagementPrivate equity1round

Samsara BioCapitalVC firm1round

Adage Capital ManagementAsset manager1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Climb Bio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

LifeArc VenturesVC firmPer its own site

Quick answers about Climb Bio

Who invested in Climb Bio?

Climb Bio's investors include RA Capital Management, Janus Henderson Investors, Cormorant Asset Management, Samsara BioCapital and Adage Capital Management.

How much has Climb Bio raised?

Climb Bio has raised $110M across 1 round since 2026.

When did Climb Bio last raise?

Climb Bio's most recent round was an Undisclosed round of $110M in Apr 2026.

What was Climb Bio's biggest round?

Its most recent round, $110M in Apr 2026, is also its largest on record.

Who backed Climb Bio first?

Climb Bio's first round on record, in Apr 2026, was backed by RA Capital Management, Janus Henderson Investors and Cormorant Asset Management and 2 others.